InvestorsHub Logo
Followers 16
Posts 1522
Boards Moderated 0
Alias Born 08/09/2011

Re: None

Tuesday, 12/14/2021 2:04:03 PM

Tuesday, December 14, 2021 2:04:03 PM

Post# of 567
The company has a new update on its website. It also presented at a national hematology meeting. The presenter is attached to MD Anderson. It just doesn't get much better then MDA. The AML product seems to work so well at increasing dosages that the company is content to continue Phase I-2 testing at even higher dosage levels until a breaking point is reached. I think that's why the stock is down so much today. Product is stellar, but getting ahead in the testing procedure is not on company radar at this time. Something will have to give if the stock drops and stays below $1.00 for a while.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News